抢先参与的临床试验
总计9033个结果
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
Ikena OncologyBristol-Myers Squibb撤销
-
University of Sao PauloSantander终止纳入标准: | 自愿参与研究,并有时间提交会议,会议持续两个月。 | 在 LSS 问卷、完成 STAI 和一般表格中获得中等、高或非常高的压力分数。 | 排除标准: | 怀孕的学生。
-
Centre Hospitalier Universitaire, AmiensRegional Council Picardie完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Emory UniversityNational Cancer Institute (NCI); Astellas Pharma Inc; Polyphenon Pharma完全的
-
OHSU Knight Cancer InstituteOregon Health and Science University; American Cancer Society, Inc.招聘中
-
Shanghai Ninth People's Hospital Affiliated to...Shanghai Jiao Tong University School of Medicine未知
-
Memorial Sloan Kettering Cancer CenterRegeneron Pharmaceuticals招聘中
-
Radiation Therapy Oncology GroupGlaxoSmithKline; Novartis完全的
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)尚未招聘
-
Glenn J. HannaImmunityBio, Inc.招聘中头颈癌 | 头颈部鳞状细胞癌 | 复发性头颈部鳞状细胞癌 | 复发性头颈癌 | 转移性头颈癌 | 转移性头颈部鳞状细胞癌美国
-
Kantonsspital Winterthur KSWUMC Utrecht; University of Lausanne; Zurich University of Applied Sciences; University of Applied... 和其他合作者尚未招聘晚期头颈部鳞状细胞癌
-
Nang Kuang Pharmaceutical Co., Ltd.终止
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)未知
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
Robert L. Ferris, MD, PhDBristol-Myers Squibb招聘中
-
Andrei IagaruNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的
-
University of California, Davis完全的头颈癌 | 创伤 | 头颈部鳞状细胞癌 | 头颈癌美国
-
Glenn J. HannaSecura Bio, Inc.主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
University of Alabama at Birmingham完全的
-
Merck Sharp & Dohme LLC完全的
-
Nektar TherapeuticsMerck Sharp & Dohme LLC; SFJ Pharmaceuticals, Inc.终止
-
University of Alabama at BirminghamAventis Pharmaceuticals完全的
-
Tactile MedicalVanderbilt University完全的
-
Danish Cancer SocietyThe Ministry of Science, Technology and Innovation, Denmark; Sygekassernes Helsefond完全的